|
ENSC Ensysce Biosciences Inc 1716947 |
| Balance Sheet |
|
Current Assets
|
$2,846,210.00 |
|
Assets
|
$2,957,273.00 |
|
Current Liabilities
|
$4,068,106.00 |
|
Liabilities
|
$4,068,106.00 |
|
Equity
|
$-781,697.00 |
|
Shares Out
|
16227518.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-5,463,383.00 |
|
Investing Cash Flow
|
$-123,643.00 |
| Market Analysis |
Market Cap
|
$6,166,456.84 |
|
Price
|
$0.38 |
|
PB
|
0.39 |
|
EPS
|
-0.20 |
|
PS
|
1.32 |
|
FCF
|
$-5,587,026.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:04 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:53 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ENSC documents filed with the SEC.
ENSC Filings
Clear
